Conference Reports for NATAP

EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom  April 9-13 Back

Sofosbuvir Plus Ribavirin, an Interferon-Free Regimen, in the Treatment of Treatment-Naïve and -Experienced Patients With Chronic Genotype 4 HCV Infection       Reported by Jules Levin EASL 2014 April 9-13 London, UK   Peter J. Ruane,1 Dani Ain,1 Raymond Meshrekey,1 Joseph Riad,1 Richard Stryker,1 Mina Soliman,1 Sam Mikhail,1 Peter R. Wolfe,1 Kathryn Kersey,2 Brian Doehle,2 Deyuan Jiang,2 William T. Symonds2 1Ruane Medical and Liver Health Institute, Los Angeles, California, USA; 2Gilead Sciences, Inc., Foster City, California